| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HC5001.100528 |
| P698 | PubMed publication ID | 11772873 |
| P50 | author | Daniel S Berman | Q89697826 |
| Leslee J Shaw | Q94570815 | ||
| Rory Hachamovitch | Q114406980 | ||
| P2093 | author name string | Gary V Heller | |
| D Douglas Miller | |||
| David D Waters | |||
| Mark I Travin | |||
| Dakshina R Murthy | |||
| Salvadore Borges-Neto | |||
| Satyendra Giri | |||
| P433 | issue | 1 | |
| P921 | main subject | computed tomography | Q32566 |
| coronary artery disease | Q844935 | ||
| single-photon emission computed tomography | Q849737 | ||
| P304 | page(s) | 32-40 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease | |
| P478 | volume | 105 |
| Q53608079 | Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial. |
| Q44392647 | Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management |
| Q35060438 | American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease--the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. |
| Q37005487 | American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). |
| Q38192519 | Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention? |
| Q34770822 | Assessment of coronary artery disease and calcified coronary plaque burden by computed tomography in patients with and without diabetes mellitus |
| Q35808209 | Assessment of prognosis in chronic coronary artery disease |
| Q36390101 | Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus |
| Q38197196 | Asymptomatic coronary artery disease in type II diabetes. |
| Q80198173 | Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease |
| Q80613471 | Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: a critical review |
| Q30435687 | Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial |
| Q35981540 | Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis |
| Q42734797 | Cardiac risk assessment in asymptomatic diabetes: combining [corrected] different imaging modalities and surrogate markers? |
| Q48128845 | Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros |
| Q45064336 | Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging |
| Q39131466 | Cardiovascular risk stratification in diabetic patients following stress single-photon emission-computed tomography myocardial perfusion imaging: the impact of achieved exercise level |
| Q34498723 | Carotid and cerebrovascular disease in symptomatic patients with type 2 diabetes: assessment of prevalence and plaque morphology by dual-source computed tomography angiography |
| Q28186232 | Clinical utility of coronary calcium scoring after nonischemic myocardial perfusion imaging |
| Q55063431 | Coronary Atherosclerosis Assessment by Coronary CT Angiography in Asymptomatic Diabetic Population: A Critical Systematic Review of the Literature and Future Perspectives. |
| Q37335175 | Coronary artery disease screening in patients with diabetes |
| Q51899702 | Coronary heart disease in women: update 2008. |
| Q36339424 | Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature |
| Q34733643 | Diagnosing coronary artery disease in diabetic patients |
| Q35087461 | Diagnosis of CAD in patients with diabetes: who to evaluate |
| Q37708142 | Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus |
| Q53349013 | Diagnostic pathway of integrated SPECT/CT for coronary artery disease. |
| Q39363912 | Evaluating gender differences in prognosis following SPECT myocardial perfusion imaging among patients with diabetes and known or suspected coronary disease in the modern era. |
| Q33944878 | Facts and principles learned at the 31st Annual Williamsburg Conference on Heart Disease. |
| Q44625504 | First Annual Mario S. Verani, md, Memorial Lecture: clinical value of myocardial perfusion imaging in coronary artery disease |
| Q84309115 | Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications |
| Q33709966 | Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial |
| Q35854008 | Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. |
| Q38818605 | Imaging Atherosclerosis in Diabetes: Current State |
| Q36350284 | Imaging techniques in nuclear cardiology for the assessment of myocardial viability |
| Q91780170 | Imaging to Stratify Coronary Artery Disease Risk in Asymptomatic Patients with Diabetes |
| Q46777219 | Impact of inducible ischemia by stress SPECT in cardiac risk assessment in diabetic patients: rationale and design of a prospective, multicenter trial |
| Q36390106 | Improved cardiac risk assessment with noninvasive measures of coronary flow reserve |
| Q44379920 | Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity |
| Q37704941 | Integration of coronary anatomy and myocardial perfusion imaging |
| Q53650435 | Is a revision of the "nuclear cardiology warranty" in order? |
| Q33582307 | Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients? |
| Q35206383 | Ischemic heart disease in type 2 diabetes |
| Q53338998 | Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study. |
| Q40536159 | Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention |
| Q57294964 | Low-dose stress-only myocardial perfusion imaging |
| Q83039004 | Monitoring effectiveness of medical therapy in 2006 |
| Q35025172 | Myocardial Perfusion SPECT Utility in Predicting Cardiovascular Events Among Indonesian Diabetic Patients |
| Q53465572 | Myocardial perfusion defects and coronary risk factors in symptomatic and asymptomatic elderly women. |
| Q44667016 | Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. |
| Q34548323 | Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus |
| Q36399456 | Myocardial perfusion imaging in diabetes mellitus |
| Q37768122 | Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review. |
| Q35765832 | Myocardial perfusion scintigraphy: the evidence |
| Q37036184 | N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status. |
| Q37638465 | Negative predictive value of SPECT for the occurrence of MACE in a medium-sized clinic in the Netherlands |
| Q30277401 | Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology |
| Q36686548 | Noninvasive assessment of the carotid and cerebrovascular atherosclerotic plaques by multidetector CT in type-2 diabetes mellitus patients with transient ischemic attack or stroke |
| Q51828003 | Predictive value of myocardial tomoscintigraphy in asymptomatic diabetic patients after percutaneous coronary intervention. |
| Q63412122 | Predictive variables for hard cardiac events and coronary revascularization in patients with normal left ventricular myocardial perfusion and systolic function |
| Q53387575 | Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus. |
| Q30413284 | Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging |
| Q44174008 | Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease |
| Q79956546 | Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms |
| Q28210945 | Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy |
| Q45163651 | Prognosis in patients with suspected or known ischemic heart disease and normal myocardial perfusion: long-term outcome and temporal risk variations |
| Q33669965 | Prognostic Value of Normal Perfusion but Impaired Left Ventricular Function in the Diabetic Heart on Quantitative Gated Myocardial Perfusion SPECT. |
| Q53417126 | Prognostic value of 64-slice coronary angiography in diabetes mellitus patients with known or suspected coronary artery disease compared with a nondiabetic population. |
| Q53267927 | Prognostic value of CT coronary angiography: focus on obstructive vs. nonobstructive disease and on the presence of left main disease. |
| Q46423841 | Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease |
| Q35723309 | Prognostic value of gated myocardial perfusion SPECT. |
| Q37255966 | Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris. |
| Q38219935 | Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: a meta-analysis. |
| Q37633902 | Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans: A Feasibility Study. |
| Q37633905 | Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion |
| Q34117439 | Recommendations for reducing radiation exposure in myocardial perfusion imaging |
| Q50193591 | Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges |
| Q40153111 | Regional wall-motion abnormalities on post-stress electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomography imaging predict cardiac events |
| Q36571194 | Review of gated SPECT imaging in women with suspected coronary heart disease |
| Q53108258 | Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging. |
| Q53544314 | SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value. |
| Q42631738 | Screening for coronary artery disease in diabetic patients: a commentary |
| Q30471287 | Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review |
| Q51951958 | Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: combined use of stress myocardial perfusion imaging and coronary calcium scoring. |
| Q36046057 | Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes |
| Q36787048 | Stress Perfusion Cardiac Magnetic Resonance Imaging Effectively Risk Stratifies Diabetic Patients With Suspected Myocardial Ischemia |
| Q35238202 | Stress imaging in patients with diabetes; routine practice? |
| Q83201234 | The WOMEN study: what is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest |
| Q36688354 | The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes |
| Q35602731 | The clinical role of stress myocardial perfusion imaging in women with suspected coronary artery disease |
| Q37715755 | The clinical use of stress echocardiography in ischemic heart disease. |
| Q48613788 | The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? |
| Q79841453 | The epidemics of obesity and type 2 diabetes: implications for noninvasive cardiovascular imaging |
| Q46790828 | The prognosis for prognosis remains excellent |
| Q50744749 | The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. |
| Q84510381 | The relationship between glycosylated hemoglobin and myocardial perfusion imaging |
| Q53601280 | The role of stress myocardial perfusion imaging in the risk stratification of patients with remote myocardial infarction. |
| Q46638084 | Third Annual Mario S. Verani, MD, Memorial Lecture: The future of clinical nuclear cardiology |
| Q51307451 | Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients. |
| Q44139472 | Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound |
| Q51499483 | Value of diagnostic tools for myocardial ischemia used in routine clinical practice to predict cardiac events in patients with type 2 diabetes mellitus: a prospective study. |
| Q38184961 | Vascular imaging in diabetes |
| Q53093385 | Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. |
| Q53056612 | Warranty periods for normal myocardial perfusion stress SPECT. |
| Q95466231 | [Cardiac imaging in (asymptomatic) diabetic patients] |
| Q53556270 | [Value of gated SPECT myocardial perfusion imaging for individual cardiac risk assessment]. |
Search more.